Spider Rock Advisors, LLC Pfizer Inc Call Options Transaction History

Spider Rock Advisors, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Oct 25, 2023	BUY	$32.09 - $37.51 $320,900 - $375,100	10,000 New	10,000 $380,000
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $343,125 - $425,175	-7,500 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $165,280 - $245,000	-4,000 Reduced 34.78%	7,500 $338,000
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $3,925 - $5,042	-100 Reduced 0.86%	11,500 $518,000
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $50,273 - $56,952	-1,400 Reduced 10.77%	11,600 $522,000

Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $365,041 - $411,693	10,900 Added 519.05%	13,000 $575,000
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $70,287 - $89,376	2,100 New	2,100 $94,000
Q3 2020 Oct 16, 2020	SELL	$31.75 - $37.25 $47,625 - $55,875	-1,500 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $45,180 - $54,810	1,500 New	1,500 $0
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $535,486 - $568,169	-16,100 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $499,100 - $549,815	16,100	16,100 $48,000

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spider Rock Advisors, LLC with notifications on news.